This Week in Startups Hims & Hers CEO Andrew Dudum on the future of healthcare post-COVID, starting a company to SPAC’ing in 36 months | E1181
7 snips
Mar 3, 2021 Andrew Dudum, Co-founder and CEO of Hims & Hers, shares insights on the future of healthcare in a post-COVID world. He discusses how the pandemic accelerated telemedicine, reshaping patient-doctor interactions and emphasizing transparency. Dudum reflects on navigating life as a public CEO after a rapid SPAC process and highlights the growing demand for online consultations. He also emphasizes patient empowerment and the need for systemic changes to enhance healthcare access and affordability, all while addressing chronic health conditions through innovative solutions.
AI Snips
Chapters
Transcript
Episode notes
Venture Studio Approach
- Atomic, a venture studio, aimed to combine venture capital pattern recognition with operator experience.
- This approach aimed for a higher success rate than traditional startups.
From Dropout to CEO
- Andrew Dudum dropped out of college to pursue entrepreneurship, founding a company acquired by Telefonica.
- He then co-founded Atomic, a venture studio, with Jack Abraham.
Generic Drug Strategy
- Hims & Hers leverages the generic drug market.
- This strategy makes medications more affordable and accessible.